BioNTech SE - ADR vs Figs Inc — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Figs Inc trades at $14.26 (market cap $2.37B). The key difference: BioNTech SE - ADR is far larger — about 9.8× Figs Inc's market cap, and Figs Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | FIGS | |
|---|---|---|
Market Cap | $23.31B | $2.37B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $17.12 |
52-Week Low | $83.89 | $6.57 |
Enterprise Value | $6.60B | $2.13B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →